GlaxoSmithKline Might Sell Its Uniliver India's Stakes for USD 3.7 Billion
#GlaxoSmithKline Might Sell Its #Uniliver India's Stakes for USD 3.7 Billion
According to some reports GlaxoSmithKline Plc is preparing to start a sale of its $3.7-billion stake in Unilever’s listed India unit.
According to Bloomberg report says Glaxo plans to offload a part or all of its 5.7 per cent holding in Hindustan Unilever through a series of block trades, which could start as soon as the next few days.
The company is in discussions with advisers on when to launch…
View On WordPress










